{"disease":{"id":"myasthaenia-gravis","name":"myasthaenia gravis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06617741","title":"Myasthenia Gravis Foundation of America Global MG Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":3800,"lead_sponsor_name":"Myasthenia Gravis Foundation of America","has_results":false},{"nct_id":"NCT04031469","title":"A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease","phase":"","overall_status":"SUSPENDED","enrollment_count":1000,"lead_sponsor_name":"ProgenaBiome","has_results":false},{"nct_id":"NCT06799247","title":"Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Cartesian Therapeutics","has_results":false},{"nct_id":"NCT06707727","title":"Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"First Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT06765161","title":"Efgartigimod in IVIG Dependent Myasthenia Gravis Patients","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Clinique Neuro-Outaouais","has_results":false},{"nct_id":"NCT07072676","title":"The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT06684184","title":"Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Zhongming Qiu","has_results":false},{"nct_id":"NCT06740656","title":"Neuromuscular Complications of MEK Inhibitors: a French Case Series and a Systematic Review of the Literature","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}